Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112321812 | 11232181 | 2 | F | 20150601 | 20150701 | 20160711 | PER | US-TEVA-560958USA | TEVA | 54.00 | YR | F | Y | 85.81000 | KG | 20160711 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112321812 | 11232181 | 1 | PS | SURMONTIL | TRIMIPRAMINE MALEATE | 1 | Unknown | 16792 | |||||||||||
| 112321812 | 11232181 | 2 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 20 MILLIGRAM DAILY; | 0 | 20 | MG | CAPSULE | QD | ||||||
| 112321812 | 11232181 | 3 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 0 | ||||||||||||
| 112321812 | 11232181 | 4 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | 0 | ||||||||||||
| 112321812 | 11232181 | 5 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 100 MILLIGRAM DAILY; | N | 0 | 50 | MG | TABLET | BID | |||||
| 112321812 | 11232181 | 6 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | N | 0 | |||||||||||
| 112321812 | 11232181 | 7 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | N | 0 | |||||||||||
| 112321812 | 11232181 | 8 | SS | NEURONTIN | GABAPENTIN | 1 | Unknown | 100 MG TWICE A DAY AND 300 MG AT NIGHTTIME | U | 0 | CAPSULE | ||||||||
| 112321812 | 11232181 | 9 | SS | NEURONTIN | GABAPENTIN | 1 | 900 MILLIGRAM DAILY; | U | 0 | 300 | MG | TID | |||||||
| 112321812 | 11232181 | 10 | C | KLONOPIN | CLONAZEPAM | 1 | 6 MILLIGRAM DAILY; | 0 | 2 | MG | TABLET | TID | |||||||
| 112321812 | 11232181 | 11 | C | KLONOPIN | CLONAZEPAM | 1 | 0 | ||||||||||||
| 112321812 | 11232181 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | ONCE A MONTH | 0 | INJECTION | ||||||||||
| 112321812 | 11232181 | 13 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 10/325 MG TABLET ONE EVERY 3 HOURS | 0 | |||||||||||
| 112321812 | 11232181 | 14 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 200 MILLIGRAM DAILY; | 0 | 200 | MG | TABLET | QD | |||||||
| 112321812 | 11232181 | 15 | C | IMIPRAMINE | IMIPRAMINE | 1 | 50 MILLIGRAM DAILY; | 0 | 50 | MG | TABLET | QD | |||||||
| 112321812 | 11232181 | 16 | C | IMIPRAMINE | IMIPRAMINE | 1 | 100 MILLIGRAM DAILY; | 0 | 100 | MG | TABLET | QD | |||||||
| 112321812 | 11232181 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112321812 | 11232181 | 2 | Panic disorder |
| 112321812 | 11232181 | 3 | Anxiety disorder |
| 112321812 | 11232181 | 4 | Depression |
| 112321812 | 11232181 | 5 | Sleep disorder |
| 112321812 | 11232181 | 6 | Panic disorder |
| 112321812 | 11232181 | 7 | Anxiety disorder |
| 112321812 | 11232181 | 8 | Systemic lupus erythematosus |
| 112321812 | 11232181 | 10 | Panic disorder |
| 112321812 | 11232181 | 11 | Anxiety disorder |
| 112321812 | 11232181 | 13 | Brain neoplasm |
| 112321812 | 11232181 | 14 | Systemic lupus erythematosus |
| 112321812 | 11232181 | 15 | Depression |
| 112321812 | 11232181 | 17 | Systemic lupus erythematosus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112321812 | 11232181 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112321812 | 11232181 | Constipation | |
| 112321812 | 11232181 | Hypersomnia | |
| 112321812 | 11232181 | Intentional product use issue | |
| 112321812 | 11232181 | Sedation | |
| 112321812 | 11232181 | Urinary retention | |
| 112321812 | 11232181 | Weight increased | |
| 112321812 | 11232181 | Withdrawal syndrome | |
| 112321812 | 11232181 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112321812 | 11232181 | 1 | 198809 | 0 | ||
| 112321812 | 11232181 | 2 | 2014 | 0 | ||
| 112321812 | 11232181 | 5 | 2013 | 2014 | 0 |